Alzamend Neuro, Inc. (ALZN) Social Stream
ALZAMEND NEURO INC (ALZN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ALZN.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-10-01 | 1 | $8 | $8 | $8 | $0.98 | 716.33% |
2022-09-30 | 2 | $15 | $8 | $11.5 | $0.98 | 1073.47% |
2023-04-21 | 1 | $1.5 | $1.5 | $1.5 | $0.98 | 53.06% |
2023-10-13 | 1 | $14.992 | $14.992 | $14.992 | $0.98 | 1429.8% |
2023-11-10 | 1 | $15 | $15 | $15 | $0.98 | 1430.61% |
Price Target Last Issued October 13, 2023
The Trend in the Analyst Price Target
Over the past 30 weeks, ALZN's average price target has gone up $13.5.
Over the past 30 weeks, ALZN's average upside potential has been 1,760.73%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-04-12 | 1 | 1.500 | 1.500 | 1.500 | 0.570 | 163.16% |
2023-04-21 | 1 | 1.500 | 1.500 | 1.500 | 0.600 | 150% |
2023-10-13 | 1 | 14.992 | 14.992 | 14.992 | 0.206 | 7177.67% |
2023-10-13 | 1 | 1.000 | 1.000 | 1.000 | 0.206 | 385.44% |
2023-11-10 | 1 | 15.000 | 15.000 | 15.000 | 1.460 | 927.4% |
ALZN Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
ALZN's average broker recommendation rating improved by 1 over the prior 25 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ALZN has a higher number of analysts covering the stock than 5.66% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, ALZAMEND NEURO INC's variance in analysts' estimates is lower than 29.47% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, ALZAMEND NEURO INC's upside potential (average analyst target price relative to current price) is greater than 514.37% of them.
- ALZN has a higher average analyst price target than 101.52% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ALZAMEND NEURO INC are CYT, GHRS, and AVTE.
View All Top Stocks by Price Target
What is the outlook for ALZN? Use POWR Ratings for clearer insight into price direction.